Switch to etravirine for HIV-positive patients receiving statin treatment: a prospective study (Q41217657)

28 September 2017

Switch to etravirine for HIV-positive patients receiving statin treatment: a prospective study (English)

1 reference

28 September 2017

12

1 reference

28 September 2017

Matthias Cavassini

2

0 references

Swiss HIV Cohort Study

14

object named as

Swiss HIV Cohort Study

1 reference

28 September 2017

13

Alexandra Calmy

1 reference

28 September 2017

11

Bernard Hirschel

1 reference

28 September 2017

Laura Ciaffi

1

1 reference

28 September 2017

Daniel Genne

3

1 reference

28 September 2017

Cecile Delhumeau

4

1 reference

28 September 2017

Rachel Spycher Elbes

5

1 reference

28 September 2017

Andrew Hill

6

1 reference

28 September 2017

Gilles Wandeler

7

1 reference

28 September 2017

Jan Fehr

8

1 reference

28 September 2017

Marcel Stoeckle

9

1 reference

28 September 2017

Patrick Schmid

10

1 reference

28 September 2017

1 July 2015

1 reference

European Journal of Clinical Investigation

28 September 2017

1 reference

28 September 2017

45

1 reference

28 September 2017

7

1 reference

28 September 2017

720-730

1 reference

Impact of HIV infection and HAART on serum lipids in men.

28 September 2017

1 reference

A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors

21 January 2018

1 reference

Hyperlipidemia and insulin resistance are induced by protease inhibitors independent of changes in body composition in patients with HIV infection

21 January 2018

1 reference

Lipodystrophy, metabolic disorders, and human immunodeficiency virus infection: Aquitaine Cohort, France, 1999. Groupe d'Epidémiologie Clinique du Syndrome d'Immunodéficience Acquise en Aquitaine

21 January 2018

1 reference

Metabolic syndrome, cardiovascular disease and type 2 diabetes mellitus after initiation of antiretroviral therapy in HIV infection

21 January 2018

1 reference

Combination antiretroviral therapy and the risk of myocardial infarction

21 January 2018

1 reference

HIV increases markers of cardiovascular risk: results from a randomized, treatment interruption trial.

21 January 2018

1 reference

Prevalence of comedications and effect of potential drug-drug interactions in the Swiss HIV Cohort Study

21 January 2018

1 reference

A randomized crossover study to compare efavirenz and etravirine treatment.

21 January 2018

1 reference

Etravirine as a Switching Option for Patients with HIV RNA Suppression: A Review of Recent Trials.

21 January 2018

1 reference

Factors associated with D-dimer levels in HIV-infected individuals

21 January 2018

1 reference

The activation of the cannabinoid receptor type 2 reduces neutrophilic protease-mediated vulnerability in atherosclerotic plaques.

21 January 2018

1 reference

Receptor activator of NF- κB ligand (RANKL) increases the release of neutrophil products associated with coronary vulnerability.

21 January 2018

1 reference

The pharmacology of statins

21 January 2018

1 reference

The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies

21 January 2018

1 reference

There is no evidence for an increase in acute coronary syndromes after short-term abrupt discontinuation of statins in stable cardiac patients

21 January 2018

1 reference

Lipid profiles for etravirine versus efavirenz in treatment-naive patients in the randomized, double-blind SENSE trial

21 January 2018

1 reference

Efficacy and safety of etravirine at week 96 in treatment-experienced HIV type-1-infected patients in the DUET-1 and DUET-2 trials

21 January 2018

1 reference

Systemic and intraplaque mediators of inflammation are increased in patients symptomatic for ischemic stroke.

21 January 2018

1 reference

Changes in cardiovascular biomarkers in HIV-infected patients switching from ritonavir-boosted protease inhibitors to raltegravir.

21 January 2018

1 reference

Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein

21 January 2018

1 reference

Rebound inflammatory response during the acute phase of myocardial infarction after simvastatin withdrawal.

21 January 2018

1 reference

Endothelial, inflammatory, coagulation, metabolic effects and safety of etravirine in HIV-uninfected volunteers

21 January 2018

1 reference

Randomised study to assess the efficacy and safety of once-daily etravirine-based regimen as a switching strategy in HIV-infected patients receiving a protease inhibitor-containing regimen. Etraswitch study

21 January 2018

1 reference

Class of Antiretroviral Drugs and the Risk of Myocardial Infarction

21 January 2018

1 reference

Longitudinal changes in serum lipids among HIV-infected men on highly active antiretroviral therapy

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/ECI.12464

1 reference

28 September 2017

1 reference